EUVIMEDEUVIMED entdecken
Open Access

Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus

Hanane El Bannoudi iD, MacIntosh Cornwell iD, Elliot Luttrell-Williams, Alexis Engel, Christina Rolling, Tessa J Barrett, Peter Izmirly, H Michael Belmont, Kelly Ruggles, Robert Clancy, Jill Buyon iD, Jeffrey S Berger

Arthritis & Rheumatology · 2023-05 · 75 (5) · 711-722

DOI: 10.1002/art.42382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 14.03.2023. Verfasst von Hanane El Bannoudi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, New York University Grossman School of Medicine, New York. Hauptthemen laut MEDLINE: Blood Platelets, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Platelets are mediators of inflammation with immune effector cell properties and have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). This study investigated the role of platelet‐associated lectin, galactoside‐binding, soluble 3 binding protein (LGALS3BP) as a mediator of inflammation in SLE and as a potential biomarker associated with clinical phenotypes.

Methods

We performed RNA sequencing on platelets from patients with SLE (n = 54) and on platelets from age‐, sex‐, and race/ethnicity‐matched healthy controls (n = 18) and measured LGALS3BP levels in platelet releasate and in circulating serum. We investigated the association between LGALS3BP levels and the prevalence, disease severity, and clinical phenotypes of SLE and studied platelet‐mediated effects on myeloid inflammation.

Results

Platelets from patients with SLE exhibited increased expression of LGALS3BP (fold change 4.0, adjusted P = 6.02 × 10 −11 ). Platelet‐released LGALS3BP levels were highly correlated with circulating LGALS3BP (R = 0.69, P < 0.0001), and circulating LGALS3BP levels were correlated with the severity of disease according to the SLE Disease Activity Index (r = 0.32, P = 0.0006). Specifically, circulating LGALS3BP levels were higher in SLE patients with lupus nephritis than in patients with inactive disease (4.0 μg/ml versus 2.3 μg/ml; P < 0.001). Interferon‐α induced LGALS3BP transcription and translation in a megakaryoblastic cell line (MEG‐01) in a dose‐dependent manner. Recombinant LGALS3BP and platelet releasates from SLE patients enhanced proinflammatory cytokine production by macrophages.

Conclusions

Our results support that platelets act as potent effector cells that contribute to the pathogenesis of SLE by secreting proinflammatory LGALS3BP, which also represents a novel biomarker of SLE clinical activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsLupus Erythematosus, SystemicHumansCarrier ProteinsInflammationBiomarkersAntigens, NeoplasmBiomarkers, TumorExtracellular Matrix Proteins

Substanzen

Carrier ProteinsBiomarkersAntigens, NeoplasmBiomarkers, TumorLGALS3BP protein, humanExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Medicine, New York University Grossman School of Medicine, New York.
  • Department of Medicine and Institute for Systems Genetics, New York University Grossman School of Medicine, New York.
  • Department of Medicine, New York University Grossman School of Medicine, New York, and Medizinische Klinik, Universitaetsklinikum Hamburg-Eppendorf.

ORCID-Profile: Hanane El Bannoudi, MacIntosh Cornwell, Jill Buyon

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIAMS NIH HHS
  • National Institutes of Health

Zitieren

APA

El Bannoudi, H., Cornwell, M., Luttrell-Williams, E., Engel, A., Rolling, C., Barrett, T. J., Izmirly, P., Belmont, H. M., Ruggles, K., Clancy, R., Buyon, J., & Berger, J. S. (2023). Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 75(5), 711-722. https://doi.org/10.1002/art.42382

Vancouver

El Bannoudi H, Cornwell M, Luttrell-Williams E, Engel A, Rolling C, Barrett TJ, et al. Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 2023;75(5):711-722. doi:10.1002/art.42382

BibTeX
@article{ElBannoudi2023,
  author = {El Bannoudi, Hanane and Cornwell, MacIntosh and Luttrell-Williams, Elliot and Engel, Alexis and Rolling, Christina and Barrett, Tessa J and Izmirly, Peter and Belmont, H Michael and Ruggles, Kelly and Clancy, Robert and Buyon, Jill and Berger, Jeffrey S},
  title = {Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  volume = {75},
  number = {5},
  pages = {711--722},
  doi = {10.1002/art.42382}
}
Kostenlos starten →